eSense-Lab
(ASX:ESE)

Latest Article

$2.6M Capped eSense-Lab Signs US$600k Revenue Deal

$2.6M Capped eSense-Lab Signs US$600k Revenue Deal

Backed by a new leadership team, ASX-listed biotech junior, eSense-Lab (ASX:ESE) is implementing a new business model that sees it enter joint venture (JV) agreements to quickly reach multiple revenue-generating markets.

Related Articles

Game Changer? ASX Stock Reverse Engineering Cannabis Plants

Game Changer? ASX Stock Reverse Engineering Cannabis Plants

Who is the ASX company with transforming qualities that could completely disrupt the cannabis and CBD markets?

Thanks for subscribing!

X